Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases

Irene Catucci, Mara Colombo, Paolo Verderio, Loris Bernard, Filomena Ficarazzi, Frederique Mariette, Monica Barile, Bernard Peissel, Elisa Cattaneo, Siranoush Manoukian, Paolo Radice, Paolo Peterlongo

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.

Original languageEnglish
Article numbere31038
JournalPLoS One
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 23 2012

Fingerprint

breast neoplasms
Genes
Breast Neoplasms
Fanconi Anemia
Germ-Line Mutation
germ cells
Italy
mutation
genes
Hereditary Neoplastic Syndromes
Fanconi Syndrome
Sample Size
risk groups
Testing
Mutation
Familial Breast Cancer
neoplasms
Population
testing
sampling

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases. / Catucci, Irene; Colombo, Mara; Verderio, Paolo; Bernard, Loris; Ficarazzi, Filomena; Mariette, Frederique; Barile, Monica; Peissel, Bernard; Cattaneo, Elisa; Manoukian, Siranoush; Radice, Paolo; Peterlongo, Paolo.

In: PLoS One, Vol. 7, No. 2, e31038, 23.02.2012.

Research output: Contribution to journalArticle

Catucci, Irene ; Colombo, Mara ; Verderio, Paolo ; Bernard, Loris ; Ficarazzi, Filomena ; Mariette, Frederique ; Barile, Monica ; Peissel, Bernard ; Cattaneo, Elisa ; Manoukian, Siranoush ; Radice, Paolo ; Peterlongo, Paolo. / Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases. In: PLoS One. 2012 ; Vol. 7, No. 2.
@article{5a303b4e37eb4ccb8841138b74fc6ee7,
title = "Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases",
abstract = "Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6{\%}. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.",
author = "Irene Catucci and Mara Colombo and Paolo Verderio and Loris Bernard and Filomena Ficarazzi and Frederique Mariette and Monica Barile and Bernard Peissel and Elisa Cattaneo and Siranoush Manoukian and Paolo Radice and Paolo Peterlongo",
year = "2012",
month = "2",
day = "23",
doi = "10.1371/journal.pone.0031038",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases

AU - Catucci, Irene

AU - Colombo, Mara

AU - Verderio, Paolo

AU - Bernard, Loris

AU - Ficarazzi, Filomena

AU - Mariette, Frederique

AU - Barile, Monica

AU - Peissel, Bernard

AU - Cattaneo, Elisa

AU - Manoukian, Siranoush

AU - Radice, Paolo

AU - Peterlongo, Paolo

PY - 2012/2/23

Y1 - 2012/2/23

N2 - Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.

AB - Breast cancer can be caused by germline mutations in several genes that are responsible for different hereditary cancer syndromes. Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer. Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk. This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy. We found 81 different germline variants and none of these were clearly pathogenic. The statistical power of our sample size allows concluding that in Italy the frequency of carriers of truncating mutations of SLX4 may not exceed 0.6%. Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population.

UR - http://www.scopus.com/inward/record.url?scp=84857617430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857617430&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0031038

DO - 10.1371/journal.pone.0031038

M3 - Article

C2 - 22383991

AN - SCOPUS:84857617430

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e31038

ER -